top of page
All posts
Alzheimer's
ANVISA
Author: Allan Matsui
Author: Jairo Utimi
Author: Claudia Cilento
Author: Nilva Bortoleto
BPF
Cannabidiol
Cancer
Cannabis
Coronavirus
Covid-19
challenges
Epilepsy
pharmaceutical
IFA
pharmaceutical industry
Inovatie
medicines
opportunities
Parkinson
pharmaceuticals
pharmaceutical industry
Author: Camille Rodrigues da Silva
Incremental innovation
Investments
Marketing
News
Incremental innovation
Good Manufacturing Practices
Search
Regulatory Intelligence and the Role of Clinical Studies
Dec 12, 2024
Anvisa publishes the list of active ingredients of medicines with registration requests under analysis
Oct 17, 2024
We must support Anvisa
Sep 12, 2024
Post-registration of medicines – opportunities and challenges
Aug 30, 2024
Clinical Research Law: A Historic Regulatory Milestone for Clinical Trial with Human Beings in Brazil
Aug 12, 2024
GGBIO task force: solution or palliative?
Aug 5, 2024
Anvisa: 25 years with many stories to tell
Jul 11, 2024
Challenges in the development and registration of biosimilars
Jun 27, 2024
Anvisa's General Management of Medicines releases the 2023 Management Report
Jun 17, 2024
Find out about Anvisa's priorities for the next biennium
Feb 7, 2024
RDC 753 - New Regulatory Framework for the Registration of Synthetic Drugs.
Nov 21, 2023
What are the challenges in ensuring access to high-cost medicines?
Nov 6, 2023
WHAT ARE THE STEPS FOR OBTAINING AUTHORIZATION FOR CLINICAL STUDIES IN BRAZIL?
Oct 26, 2023
Important circumstances for the submission of drug registration in Brazil
Oct 9, 2023
What are the topics of interest and ANVISA’s availability for meetings?
Sep 29, 2023
What is the purpose of registration submission guide, based on data from scientific literature?
Aug 22, 2023
Biological and biosimilar medicines - development and commercialization challenges
Jul 24, 2023
What was the impact of the pandemic on clinical studies?
Jan 4, 2023
Clinical research in Brazil - regulation is important and urgent!
Apr 7, 2022
E-BOOKS
CONTEÚDOS EXCLUSIVOS PARA AUXILIAR EM
SEU TRABALHO
Acesse
bottom of page
